Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Biomonitoring Device Improves Detection of Toxic Metals

By Labmedica staff writers
Posted on 25 Feb 2008
A new rapid, portable, and inexpensive detection system has been developed that identifies personal exposures to toxic lead and other dangerous heavy metals. More...
The device can provide an accurate blood sample measurement from a simple finger prick, which is particularly important when sampling children.

Accumulation of lead in children can harm the developing brain, causing reduced IQ, learning disabilities, and behavioral problems, among other things. The U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) report that about 310,000 U.S. children ages one to five have high levels of lead in their blood. Recent studies also indicate a link between lead exposure and a decline in mental ability many years later. In addition, large numbers of industrial workers are routinely exposed to toxic heavy metals such as cadmium, lead, and mercury, which are known to induce various diseases.

The new analyzer system accurately detects lead and other toxic metals in urine and saliva as well as in blood. The device may be as much as 10 times less expensive than current plasma mass spectrometry (MS) systems, which require samples to be returned to the lab for time-consuming and expensive analysis The new system provides an excellent method of monitoring toxic metal exposures in high-risk populations, such as industrial workers, children, and people living in polluted areas.

Two classes of sensors are used for detecting lead and other heavy metals. The first is based on a flow injection system using a mercury-film electrode to analyze metals in blood, urine, or saliva samples. The second is based on a mercury-free approach of nanostructure materials. It either uses self-assembled monolayers on mesoporous supports (SAMMS) technology--or functionalized magnetic nanoparticles that provide excellent detection sensitivity at a ppb level.

A product of The U.S. Department of Energy's (DOE) Pacific Northwest National Laboratory (PNNL; Richland, WA, USA), the monitoring device is a bit larger than a lunchbox, and is suitable for use in the field. It has plug-and-play features that allow different sensors to be easily exchanged to detect a variety of heavy metal toxins. The entire system is battery-operated, and requires about 50% more power than a typical laptop computer.

Battelle, which operates PNNL for the DOE, filed a patent application in December 2007 for the improved sensor technology used in this next-generation biomonitoring device.


Related Links:
U.S. Centers for Disease Control and Prevention
U.S. Department of Energy's Pacific Northwest National Laboratory
Battelle

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.